Basic information Safety Supplier Related

Ampalex

Basic information Safety Supplier Related

Ampalex Basic information

Product Name:
Ampalex
Synonyms:
  • CX516; BDP 12; AMPAKINE CX516
  • BDP-12(Ampalex)
  • ABT-224,PIPERIDINE, 1-(6-QUINOXALINYLCARBONYL)-
  • 1-(QUINOXALIN-6-YLCARBONYL)PIPERIDINE
  • Ampalex
  • Piperidin-1-yl-quinoxalin-6-ylmethanone
  • Methanone, 1-piperidinyl-6-quinoxalinyl-
  • 1-(6-Quinoxalinylcarbonyl)piperidine
CAS:
154235-83-3
MF:
C14H15N3O
MW:
241.29
EINECS:
200-256-5
Product Categories:
  • Inhibitors
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • API intermediates
Mol File:
154235-83-3.mol
More
Less

Ampalex Chemical Properties

Melting point:
88-90°C
Boiling point:
433.1±25.0 °C(Predicted)
Density 
1.236±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
Chloroform, Methanol
pka
-0.14±0.30(Predicted)
form 
powder
color 
white to light brown
Water Solubility 
H2O: 5mg/mL, clear
More
Less

Safety Information

RTECS 
TM2785170
More
Less

Ampalex Usage And Synthesis

Chemical Properties

Tan Solid

Uses

Ampalex is a AMPA modulator that may exhibit therapeutic properties for treating Alzheimer''s disease, schizophrenia, and mild cognitive impairment (MCI) (1,2,3,4).

Uses

It is one of a series of AMPA modulators

Definition

ChEBI: CX-516 is a N-acylpiperidine.

Biochem/physiol Actions

CX516 is a positive allosteric modulator at AMPA receptor that inhibits the deactivation of AMPA receptors. CX-516 is a nootropic and ampakine agent.

in vivo

The specific extradimensional deficits produced by sub-chronic or early postnatal postnatal phencyclidine treatment were significantly attenuated by CX516 (10, and 20 mg/kg, s.c.)[1].

Animal Model:Male Lister Hooded rats (56-63 postnatal day)[1]
Dosage:5, 10, 20, and 40 mg/kg
Administration:Subcutaneously
Result:Two doses (10 and 20 mg/kg) were highly significant in improving the extradimensional shift deficit induced by either treatment regimes.
Two doses (5 and 40 mg/kg) was ineffective at reversing the extradimensional impairment induced by the sub-chronic postnatal phencyclidine treatment regime.

AmpalexSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com
Capot Chemical Co., Ltd
Tel
+86 (0) 571 85 58 67 18